More on APGE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $134.08 |
|
|||
| Open | $134.11 | ||||
| 52 Wk High | $0.02 | ||||
| 52 Wk Low | $0.02 | ||||
| Day High | $134.35 | ||||
| Day Low | $134.02 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 691,295 | ||||
- Form 4 Apogee Therapeutics, For: Jul 14 Filed by: Dambkowski Carl
- Form DEFM14A Apogee Therapeutics,
- Form 4 Apogee Therapeutics, For: Jul 08 Filed by: HENDERSON MICHAEL THOMAS
- Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: WELLINGTON MANAGEMENT GROUP LLP
- Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: T. Rowe Price Investment Management, Inc.
- Form SCHEDULE 13G/A Apogee Therapeutics, Filed by: FMR LLC
- Form 4 Apogee Therapeutics, For: Jul 01 Filed by: Dambkowski Carl
- Form PREM14A Apogee Therapeutics, For: Jul 02
- Shareholder Alert: Ademi LLP investigates whether Apogee Therapeutics is obtaining a Fair Price for Public Shareholders
- Form 144 Apogee Therapeutics, Filed by: Dambkowski Carl
Entities mentioned with APGE
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Jefferies & Co | View Related Stories »
- Stifel | View Related Stories »
- 13G | View Related Stories »
- Cowen & Co | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
